DLGAP1 and gastric cancer: By conducting combined functional assays such as cell proliferation assay, clonogenic assay, apoptotic assay, Transwell assay, and xenograft model, we were able to demonstrate that DLGAP1-AS2 drove the malignancy and progression of GC.